Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$952K Hold
4,375
0.46% 38
2025
Q4
$1,000K Hold
4,375
0.46% 39
2025
Q3
$1.01M Hold
4,375
0.48% 37
2025
Q2
$812K Hold
4,375
0.4% 46
2025
Q1
$917K Hold
4,375
0.54% 39
2024
Q4
$777K Hold
4,375
0.44% 38
2024
Q3
$864K Hold
4,375
0.48% 36
2024
Q2
$750K Hold
4,375
0.44% 40
2024
Q1
$797K Hold
4,375
0.48% 37
2023
Q4
$678K Buy
4,375
+525
+14% +$76.5K 0.46% 37
2023
Q3
$574K Buy
+3,850
New +$565K 0.44% 47
2023
Q2
Sell
-3,995
Closed -$637K 125
2023
Q1
$637K Buy
3,995
+400
+11% +$61.2K 0.5% 37
2022
Q4
$581K Buy
+3,595
New +$551K 0.52% 42
2022
Q3
Sell
-2,450
Closed -$375K 45
2022
Q2
$375K Buy
+2,450
New +$374K 0.24% 27

Other funds holding ABBV

Alpha Family Trust's ABBV Position: Q1 2026 in Review

Alpha Family Trust held its AbbVie (ABBV) position steady in Q1 2026 at 4,375 shares worth $952K. The position accounts for 0.46% of the portfolio, ranked #38.

Alpha Family Trust first reported a position in ABBV in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.01M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Alpha Family Trust held 4,375 shares of AbbVie worth $952K as of Q1 2026.
  • Alpha Family Trust left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.46% of Alpha Family Trust's portfolio in Q1 2026, its #38 holding.
  • Alpha Family Trust first reported a position in AbbVie in Q2 2022 and has held it in 14 quarters since.
  • Alpha Family Trust's AbbVie position peaked at $1.01M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Alpha Family Trust's 13F filing for Q1 2026, filed 13 May 2026.